Scientists use computer models to predict best patients for new bowel disease treatment
NCT ID NCT07120152
Summary
This study uses computer simulations to understand how a new under-the-skin version of the drug infliximab works in people with inflammatory bowel disease (IBD). Researchers will analyze data from previous trials to predict which patients might benefit most from switching to this new formulation. The goal is to answer important questions before starting a larger clinical trial with real patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IBD - INFLAMMATORY BOWEL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.